Skip to main content
. 2022 Jun 3;20(9):1365–1378. doi: 10.1158/1541-7786.MCR-21-1018

Table 1.

List of cell lines with PPM1D truncating mutations, amplifications, and copy-number gains curated from the Cell Model Passports database.

Cell line Cancer type Nucleotide change Amino acid change Classification TP53 status
SUP-T1 TALL c.1528_1529insA p.N512fs*16 Frameshift 1
MN-60 BALL p.N512fs*2 c.1529delA Frameshift 0
HCC1569 BRCA c.1344delT p.L450fs*1 Frameshift 1
PA-1 OV c.1370delC p.A457fs*8 Frameshift 0
PA-1 OV p.A457fs*8 c.1370delC Frameshift 0
U2OS OS c.1372C>T p.R458* Nonsense 0
BB58-HNC HNC p.N477fs*6 c.1427delA Frameshift 0
CCK-81 CRC p.N512fs*2 c.1529delA Frameshift 1
CL-34 CRC p.R572* c.1714C>T Nonsense 1
CW-2 CRC p.K336fs*3 c.1003delA Frameshift 0
HCM-SANG-520-C18 CRC p.N512fs*2 c.1529delA Frameshift 1
HCT-116 CRC c.1344delT p.L450fs*1 Frameshift 0
SNU-175 CRC p.N512fs*16 c.1528_1529insA Frameshift 0
HEC-108 EC p.L546fs*1 c.1632delC Frameshift 1
HEC-6 EC p.N512fs*16 c.1528_1529insA Frameshift 1
NCI-H3122 NSCLC p.N512fs*16 c.1528_1529insA Frameshift 1
Cell line Cancer type Copy number Cell line Cancer type Copy number
ZR-75-30 BRCA 40 NCI-H650 NSCLC 5
MCF7 BRCA 30 LN-229 GBM 5
HCC2218 BRCA 23 NCI-H2081 SCLC 5
BT-474 BRCA 23 KATOIII GC 5
MDA-MB-361 BRCA 9 CFPAC-1 PC 5
SK-MEL-5 MEL 7 NCI-H64 SCLC 5
HCC1428 BRCA 7 NCI-H740 SCLC 5
UACC-893 BRCA 7 SK-MEL-3 MEL 5
NCI-H508 CRC 7 DAN-G PC 5
CAKI-1 RCC 6 SK-MES-1 SqCLC 5
NCI-H28 MS 6 SW780 BC 5
U-2-OS OS 6 SK-N-DZ NB 5
NCI-H1993 NSCLC 6 NCI-H2009 NSCLC 4
PANC-02-03 PaC 6 MDA-MB-453 BRCA 4
SK-MEL-1 MEL 6 MHH-ES-1 EW 3
PC-3 PrC 5 NCI-H2405 NSCLC 3
MDA-MB-330 BRCA 5 MOLT-4 TALL 3

Abbreviations: BALL, B-cell acute myeloid leukemia; BC, bladder cancer; BRCA, breast cancer; CRC, colorectal; EC, endometrial carcinoma; GBM, glioblastoma; GC, gastric cancer; MEL, melanoma; MS, mesothelioma; NB, neuroblastoma; OS, osteosarcoma; OV, ovarian carcinoma; PaC, pancreatic cancer; PrC, prostate cancer; RCC, renal cell carcinoma; SCLC, small cell lung cancer; TALL, T-cell acute lymphoblastic leukemia.